Mayer Eldon C. III 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+98,000→ 98,000 totalExercise: $1.71Exp: 2033-02-28→ Common Stock (98,000 underlying)
Footnotes (1)
- [F1]. The option vests in 48 equal monthly installments commencing on the grant date of March 1, 2023, subject to the Reporting Person's continuous service as of such date.